EMEA-003165-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Uro-nephrology
PIP number: P/0474/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral (liquid or solid) dosage form
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Cabazitaxel Accord
cabazitaxel
Prostatic Neoplasms, Castration-Resistant
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanAuthorised
Jevtana
cabazitaxel
Prostatic Neoplasms
Date of authorisation:
Revision: 23
Last updated:
MedicineHumanAuthorised
Cabazitaxel Teva
cabazitaxel
Prostatic Neoplasms
Date of refusal:
Last updated:
MedicineHumanRefused